Filtered By:
Specialty: Pharmaceuticals

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 890 results found since Jan 2013.

Stroke Risk Up for Patients With Inflammatory Bowel Disease
THURSDAY, June 15, 2023 -- Patients with inflammatory bowel disease (IBD) have increased risk of stroke, according to a study published online June 14 in Neurology. Jiangwei Sun, Ph.D., from the Karolinska Institute in Stockholm, and colleagues...
Source: Drugs.com - Pharma News - June 15, 2023 Category: Pharmaceuticals Source Type: news

Women With Migraine Have Higher Risk for Heart Attack, Hemorrhagic Stroke
TUESDAY, June 13, 2023 -- The risk for ischemic stroke in individuals with migraine is similar for men and women, while the risk for myocardial infarction (MI) and hemorrhagic stroke is only higher in women with migraine, according to a study...
Source: Drugs.com - Pharma News - June 13, 2023 Category: Pharmaceuticals Source Type: news

How To Avoid Heat Stroke During Summer Heat Waves
With temps rising and expected to pass even last year's record high numbers across much of the country, follow these tips to avoid heat-related injuries and illness.
Source: Forbes.com Healthcare News - June 13, 2023 Category: Pharmaceuticals Authors: Daryl Austin, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

How To Avoid Heat Stroke During This Scorcher Of A Summer
With temps rising and expected to pass even last year's record high numbers across much of the country, follow these tips to avoid heat-related injuries and illness.
Source: Forbes.com Healthcare News - June 13, 2023 Category: Pharmaceuticals Authors: Daryl Austin, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

Incomplete ED Neurovascular Imaging Tied to Higher Odds of 90-Day Stroke
TUESDAY, June 13, 2023 -- Emergency department visits for transient ischemic attack (TIA) with incomplete neurovascular imaging are associated with higher odds of subsequent stroke within 90 days, according to a study published online May 31 in the...
Source: Drugs.com - Pharma News - June 13, 2023 Category: Pharmaceuticals Source Type: news

Risk for Stroke Increased in Association With Insomnia Symptoms
FRIDAY, June 9, 2023 -- Insomnia symptoms are associated with an increased risk for stroke, with a dose-response relationship, according to a study published online June 7 in Neurology. Wendemi Sawadogo, M.D., M.P.H., from Virginia Commonwealth...
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news

Higher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 -- For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an excellent outcome,...
Source: Drugs.com - Pharma News - June 5, 2023 Category: Pharmaceuticals Source Type: news

Early Treatment Can Be Initiated for A-Fib Patients With Stroke
MONDAY, June 5, 2023 -- For patients with atrial fibrillation who have had an acute ischemic stroke, the incidence of a composite primary end point ranges from a reduction of about 2.8 percent to an increase of 0.5 percent for those receiving early...
Source: Drugs.com - Pharma News - June 5, 2023 Category: Pharmaceuticals Source Type: news

Cancer Patients Who Continue Smoking After Diagnosis at Risk of CVD Events
FRIDAY, June 2, 2023 -- Cancer patients who continue smoking after their diagnosis have an increased risk for heart attack, stroke, or death due to cardiovascular disease (CVD) compared with nonsmokers, according to a study published online June 1...
Source: Drugs.com - Pharma News - June 2, 2023 Category: Pharmaceuticals Source Type: news

CVD Events Increased for Cancer Patients Who Continue Smoking After Diagnosis
FRIDAY, June 2, 2023 -- Cancer patients who continue smoking after their diagnosis have an increased risk for heart attack, stroke, or death due to cardiovascular disease (CVD) compared with nonsmokers, according to a study published online June 1...
Source: Drugs.com - Pharma News - June 2, 2023 Category: Pharmaceuticals Source Type: news

NeuroTrauma Sciences Commences First-in-Human Dosing in the US of Investigational Neuroprotective Drug NTS-104
Phase 1 safety study of NTS-104 is initiated in healthy volunteers Compound is being developed for stroke and other Central Nervous System (CNS) injuries ATLANTA, June 1, 2023 -- (Healthcare Sales & Marketing Network) -- NeuroTrauma Sciences, LLC (N... Biopharmaceuticals, Neurology, Drug Delivery NeuroTrauma Sciences, neurosteroid prodrug, stroke
Source: HSMN NewsFeed - June 1, 2023 Category: Pharmaceuticals Source Type: news

Why You Should Pay Attention To Diabetes
This means that more than 1 in 3 Americans has prediabetes, which is more than the number of Americans that have cancer, heart disease, or stroke.
Source: Forbes.com Healthcare News - June 1, 2023 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

Adverse Pregnancy Outcomes Increase Stroke Risk at an Earlier Age
TUESDAY, May 30, 2023 -- Women who experience an adverse pregnancy outcome (APO) have a higher risk of having a stroke in their lifetime, and at a younger age, according to a study published online May 22 in Stroke. Eliza C. Miller, M.D., from...
Source: Drugs.com - Pharma News - May 30, 2023 Category: Pharmaceuticals Source Type: news

New calculator demonstrates how improved adherence to anti-diabetic medicines can benefit people in Medicaid
Diabetes is a scary diagnosis for anyone. When people with the disease struggle to manage their blood sugar levels, they can experience significant, life-threatening and costly complications such as heart attack, stroke, kidney failure, amputation and blindness. Fortunately, diabetescan be well-managed with comprehensive access to health care services, including medicines.
Source: The Catalyst - May 25, 2023 Category: Pharmaceuticals Authors: Reid Porter Tags: Diabetes Adherence Medicaid Source Type: news

Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
RARITAN, NJ, May 25, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that all three prospective indications for milvexian, an investigational oral factor XIa (FXIa) inhibitor (being developed in collaboration with Bristol Myers Squibb), have now been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). The designations cover all three indication-seeking studies within the Phase 3 Librexia development program (Librexia STROKE, Librexia ACS and Librexia AF), which are all dosing patients. The Librexia program is unrivaled as the most comprehensive FXIa clinical...
Source: Johnson and Johnson - May 25, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news